美股A股
StockGist
Back
6-K2026-03-24· x-ai/grok-4.1-fast

ENLV · Enlivex Therapeutics Ltd.

0001213900-26-033240

SEC filing

Summary

Enlivex Ltd. entered into a Securities Purchase Agreement dated March 23, 2026, for a $21 million senior secured convertible promissory note with Lind Global Asset Management XIV LLC, providing net proceeds of approximately $18.7 million. The company also exercised an option to acquire 3,030,303,030 RAIN tokens for $10 million, extended a larger RAIN token option, and approved a $20 million ordinary share repurchase program.

Key takeaways